Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression

Translational Psychiatry(2021)10.1038/s41398-021-01442-3Source: DataRank Database

Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression is a research paper published in Translational Psychiatry (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.15)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Robert Leech ORCID,Steven Williams ORCID,Carlos A. Zarate ORCID,Rosalyn Moran ORCID,Jessica R. Gilbert ORCID

Live enrichment

PubMed:34052834 PMC:PMC8164631 OpenAlex:https://openalex.org/W3128669940

Medical Research Council

Grant: MR/R005370/1

Intramural NIH HHS

Grant: Z01 MH002857

Intramural NIH HHS

Grant: ZIA MH002857

Wellcome Trust

Grant: 203148

King's College London Medical Engineering Centre of Research Excellence

National Institutes of Health

Grant: 1ZIAMH002857-06

Glutamatergic Modulators for Rapid & Sustained Antidepressant Effect

Wellcome Trust

FWCI

0.15

Citation Percentile

0.5%

Citation Trend

2021

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41398-021-01442-3.pdf

GOLDhttps://www.nature.com/articles/s41398-021-01442-3.pdf

publisherhttps://www.nature.com/articles/s41398-021-01442-3.pdf

publisherhttps://www.nature.com/articles/s41398-021-01442-3

journalhttps://doi.org/10.1038/s41398-021-01442-3

Fields of Study

Treatment of Major DepressionFunctional Brain Connectivity StudiesMental Health Research TopicsMedicineBiologyPsychology0301 basic medicine03 medical and health sciences0302 clinical medicineDepressionMajor Depressive DisorderDepressive Disorder, Treatment-ResistantExcitatory Amino Acid AntagonistsHumansInfusions, IntravenousKetamineTreatment Outcome

MeSH Terms

DepressionDepressive Disorder, MajorMajor Depressive DisorderHumansInfusions, IntravenousKetamineTreatment OutcomeExcitatory Amino Acid AntagonistsDepressive Disorder, Treatment-Resistant

Keywords

KetamineNeuroscienceMajor depressive disorderPsychologyNMDA receptorTreatment-resistant depressionAnesthesiaMedicineInternal medicineCognitionDepressionNeurosciences. Biological psychiatry. NeuropsychiatryQuantitative Biology - Quantitative MethodsArticleDepressive Disorder, Treatment-ResistantTreatment OutcomeFOS: Biological sciencesHumansInfusions, IntravenousExcitatory Amino Acid AntagonistsQuantitative Methods (q-bio.QM)RC321-571

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequalitySDG 0: Good health and well-being

Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression

FAIR Checklist

Authors (6)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)